osimertinib
astrazeneca
['nsclc', 'sclc', 'osimertinib', 'lcsm,(-blcsm)', 'articuno']
 activity of #osimertinib in #nsclc with uncommon #egfr mutations take a look at the update of #articuno study at #esmo22, now with the largest known dataset #lcsm 
MD, Medical Oncologist @ospNiguarda and Researcher @LaStatale #LCSM #ThoracicOncology Always find a way to have fun!